Increasingly common in daily practice, this is the first guideline update since 2011, aimed to improve success rates and cut complications.
LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback